VENMAXPharmaceuticals
Venmax Drugs & Pharmaceuticals Inc — PE Ratio & Valuation Analysis
₹25.77
-2.15%
Current P/E45.94xPrice to earnings
Industry P/E31.77xSector average
⚠️
44.6% Premium to Industry
VENMAX P/E 45.94x vs sector avg 31.77x
💡
Understanding Venmax Drugs & Pharmaceuticals Inc Valuation
Venmax Drugs & Pharmaceuticals Inc (VENMAX) currently trades at 45.94x earnings. The Pharmaceuticals sector average PE is 31.77x. VENMAX commands a premium, reflecting high growth expectations. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
6.38%
Dividend Yield
0.00%
More on Venmax Drugs & Pharmaceuticals Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.